Vladimir Vigdorovich

Dr. Vladimir Vigdorovich

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2001 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SRSharath K. Rai
Sharath K. Rai
FDFuh-Mei Duh
Fuh-Mei Duh
VVVladimir Vigdorovich
Vladimir Vigdorovich
ADAlla Danilkovitch-Miagkova
Alla Danilkovitch-Miagkova
MLMichael I. Lerman
Michael I. Lerman
AMA. Dusty Miller
A. Dusty Miller
Jaagsiekte sheep retrovirus (JSRV) can induce rapid, multifocal lung cancer, but JSRV is a simple retrovirus having no known oncogenes. Here we show that the envelope ( env ) gene of JSRV has the unusual property that it can induce transformation in rat fibroblasts, and thus is likely to be responsible for oncogenesis in animals. Retrovirus entry into cells is mediated by Env interaction with particular cell-surface receptors, and we have used phenotypic screening of radiation hybrid cell lines to identify the candidate lung cancer tumor suppressor HYAL2/LUCA2 as the receptor for JSRV. HYAL2 was previously described as a lysosomal hyaluronidase, but we show that HYAL2 is actually a glycosylphosphatidylinositol (GPI)-anchored cell-surface protein. Furthermore, we could not detect hyaluronidase activity associated with or secreted by cells expressing HYAL2, whereas we could easily detect such activity from cells expressing the related serum hyaluronidase HYAL1. Although the function of HYAL2 is currently unknown, other GPI-anchored proteins are involved in signal transduction, and some mediate mitogenic responses, suggesting a potential role of HYAL2 in JSRV Env-mediated oncogenesis. Lung cancer induced by JSRV closely resembles human bronchiolo-alveolar carcinoma, a disease that is increasing in frequency and now accounts for ≈25% of all lung cancer. The finding that JSRV env is oncogenic and the identification of HYAL2 as the JSRV receptor provide tools for further investigation of the mechanism of JSRV oncogenesis and its relationship to human bronchiolo-alveolar carcinoma.

1 May 2013 in Structure
Verified
Journal Article
Closed access
VVVladimir Vigdorovich
Vladimir Vigdorovich
URUdupi A. Ramagopal
Udupi A. Ramagopal
ELEszter Lázár-Molnár
Eszter Lázár-Molnár
ESEliezer Sylvestre
Eliezer Sylvestre
JLJun Sik Lee
Jun Sik Lee
SASteven C. Almo
Steven C. Almo

1 February 2004 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
TTThomas J. Templeton
Thomas J. Templeton
CLCheryl A. Lancto
Cheryl A. Lancto
VVVladimir Vigdorovich
Vladimir Vigdorovich
CLChang Liu
Chang Liu
NLNicole R. London
Nicole R. London
MAMitchell S. Abrahamsen
Mitchell S. Abrahamsen
Coccidian parasites are transmitted via a fecal oocyst stage that is exceptionally resistant to environmental stress and harsh chemical treatments, which allows parasites to stably persist outside a host. Because of its oocyst durability Cryptosporidium parvum is a significant water- and food-borne pathogen of humans, as well as animals of agricultural importance. To date, only one apicomplexan oocyst membrane protein has been identified, Cryptosporidium oocyst wall protein 1 (COWP1). COWP1 has a highly cysteine-rich periodicity due to arrays of two apicomplexan-specific motifs, designated the type I and type II domains. In this study, exhaustive BLAST screening of a complete C. parvum genome sequence database resulted in identification of eight additional genes encoding similar arrays of cysteine-rich type I and/or type II domains. Transcript expression analysis revealed that all COWP genes are abundantly expressed at a time when developing oocysts are observed, roughly 48 to 72 h after inoculation of in vitro cultures. A monoclonal antibody recognizing COWP8 specifically localized to the C. parvum oocyst wall, supporting the hypothesis that multiple COWPs play a role in the oocyst wall structure. BLAST screening of the Toxoplasma gondii genome sequence database resulted in identification of a gene encoding at least one COWP homolog ( Tg OWP1), and this multiexon sequence information was used to isolate a full-length cDNA. Exhaustive screening of Plasmodium sp. genome sequence databases by using COWP genes as BLAST queries failed to detect similar proteins in Plasmodium . We therefore propose that the COWP family of proteins have a structural role in apicomplexan species that produce durable shed cysts capable of surviving environmental stress.

31 August 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
CCChristopher A. Cottrell
Christopher A. Cottrell
JSJelle van Schooten
Jelle van Schooten
CBCharles A. Bowman
Charles A. Bowman
MYMeng Yuan
Meng Yuan
DODavid Oyen
David Oyen
MGMarit van Gils
Marit van Gils
The induction of broad and potent immunity by vaccines is the key focus of research efforts aimed at protecting against HIV-1 infection. Soluble native-like HIV-1 envelope glycoproteins have shown promise as vaccine candidates as they can induce potent autologous neutralizing responses in rabbits and non-human primates. In this study, monoclonal antibodies were isolated and characterized from rhesus macaques immunized with the BG505 SOSIP.664 trimer to better understand vaccine-induced antibody responses. Our studies reveal a diverse landscape of antibodies recognizing immunodominant strain-specific epitopes and non-neutralizing neo-epitopes. Additionally, we isolated a subset of mAbs against an epitope cluster at the gp120-gp41 interface that recognize the highly conserved fusion peptide and the glycan at position 88 and have characteristics akin to several human-derived broadly neutralizing antibodies. Major efforts are currently directed towards developing vaccine strategies to successfully elicit broadly neutralizing antibodies (bNAbs) against HIV-1. However, how to achieve this goal remains a critical problem. Soluble native-like HIV-1 envelope glycoproteins (Env) have shown promise as vaccine candidates in pre-clinical studies. Here, the antibody response against the BG505 SOSIP.664 Env trimer was studied through the isolation of monoclonal antibodies (mAbs) in rhesus macaques (RMs) after immunization. Overall, a diverse landscape of mAbs was elicited that target the Env trimer in highly similar ways in two animals. By mapping the target epitopes of all of the mAbs isolated from the immunized RMs, rather than focusing only on the neutralizing mAbs, we were able to identify several non-neutralizing and potentially immunodominant epitopes that would ideally be eliminated in future immunization studies. In addition, we identified neutralizing mAbs that recognize the highly conserved fusion peptide in a similar way as human broadly neutralizing antibodies. These insights can be further used to develop immunogens and immunization strategies able to induce bNAb-like responses that can protect against infection.

21 April 2009 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
KCKausik Chattopadhyay
Kausik Chattopadhyay
ELEszter Lazar‐Molnar
Eszter Lazar‐Molnar
QYQingrong Yan
Qingrong Yan
RRRotem Rubinstein
Rotem Rubinstein
CZChenyang Zhan
Chenyang Zhan
SASteven C Almo
Steven C Almo

15 December 2021 in eLife
Verified
Journal Article
Open access
FMFred D Mast
Fred D Mast
PFPeter C Fridy
Peter C Fridy
NKNatalia E Ketaren
Natalia E Ketaren
JWJunjie Wang
Junjie Wang
EJErica Y Jacobs
Erica Y Jacobs
MRMichael P Rout
Michael P Rout
The emergence of SARS-CoV-2 variants threatens current vaccines and therapeutic antibodies and urgently demands powerful new therapeutics that can resist viral escape. We therefore generated a large nanobody repertoire to saturate the distinct and highly conserved available epitope space of SARS-CoV-2 spike, including the S1 receptor binding domain, N-terminal domain, and the S2 subunit, to identify new nanobody binding sites that may reflect novel mechanisms of viral neutralization. Structural mapping and functional assays show that indeed these highly stable monovalent nanobodies potently inhibit SARS-CoV-2 infection, display numerous neutralization mechanisms, are effective against emerging variants of concern, and are resistant to mutational escape. Rational combinations of these nanobodies that bind to distinct sites within and between spike subunits exhibit extraordinary synergy and suggest multiple tailored therapeutic and prophylactic strategies.